What patents or publications are linked to Neurocept founders or leadership?

Checked on December 4, 2025
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Available sources show patents assigned to companies named “Neurotech” or “Neurotech USA, Inc.” listing inventors Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao and Konrad A. Kauper, with patents filed December 4, 2023 and a grant date shown as July 15, 2025 (patent numbers cited in Justia listings) [1] [2]. Search results otherwise provide broad background on neurotech patenting trends and unrelated organizations named Neurocept or Neuroleadership but do not directly link Neurocept’s founders or leadership to publications or patents in the provided material [3] [4].

1. What the patent records in our results actually say

Justia listings for assignees “Neurotech” and “Neurotech USA, Inc.” identify patents naming inventors Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao and Konrad A. Kauper and show filing dates of December 4, 2023 and a grant date of July 15, 2025 with patent numbers referenced in the snippets [1] [2]. One Justia entry explicitly gives an abstract summary—methods and devices for long‑term treatment of ophthalmic disorders—under Neurotech USA, Inc. [2]. Those entries establish inventor names tied to a company labelled Neurotech/Neurotech USA, Inc. in the search results set [1] [2].

2. What the results do not show about “founders or leadership”

The search results do not provide corporate leadership lists, founder bios, or a clear mapping from those inventor names to a firm’s C‑suite or founder status. Available sources do not mention founders or leadership roles linking Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao or Konrad A. Kauper to being founders or executives of Neurotech — the pages instead list inventor names on patent records [1] [2]. Any claim that these inventors are company founders is not supported by the provided sources.

3. Broader patent landscape context the sources supply

Separate pieces in the results place the Neurotech-related patents into a wider pattern: reporting shows accelerating patent activity in neurotechnology broadly and that many players (including large tech firms) are active in filing, while commentators warn about ethical and regulatory implications of neurotech patenting [3] [5]. These contextual items show why inventor‑level patent listings matter for competitive and regulatory attention but do not tie specific leadership biographies to patents [3] [5].

4. Confounding names and unrelated “Neuro‑” entities

The corpus includes items about Neuroleadership and a consumer product called Neurocept, but those are distinct entities with separate public footprints. Reviews and press items about Neurocept (a brain supplement) appear in the search results but do not contain patent or founder linkage to the Neurotech / Neurotech USA, Inc. patent entries in Justia [4] [6]. Treating similarly named organizations as the same would risk conflating unrelated actors; the provided records do not support conflation [4] [6].

5. How to verify founders/leadership against patents (next steps)

To confirm whether cited inventors are founders or company leaders you need documents that explicitly list corporate officers—company websites, SEC/filing records, press releases or LinkedIn profiles—none of which appear in the supplied results. The current reporting does not include those corporate‑leadership sources, so verification is not found in the material provided (available sources do not mention founder/leadership biographies connected to the patent inventors) [1] [2].

6. Bottom line for your inquiry

The provided sources directly link specific inventors to patents assigned to entities called Neurotech/Neurotech USA, Inc. (Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao, Konrad A. Kauper) and describe at least one technical area (ophthalmic treatment devices) for the filings [1] [2]. The sources do not document whether these inventors are company founders or other leadership, and they do not provide publications authored by those named individuals within this result set (available sources do not mention founder/leadership roles or publications tied to those inventors) [1] [2].

If you want, I can draft precise search queries or a short list of documents to look for next (company filings, press releases, LinkedIn profiles, PubMed/Google Scholar searches) that would confirm leadership ties or list publications; those sources were not included in the material you provided.

Want to dive deeper?
Which patents list Neurocept founders as inventors and what do they cover?
What peer-reviewed publications have Neurocept leadership authored and where were they published?
Are there patents assigned to Neurocept or licensed from universities linked to its founders?
How have Neurocept founders' patents influenced the company's product development and regulatory filings?
Have any legal disputes or challenges involved patents or publications tied to Neurocept leadership?